FINDINGS RELEASED FROM NAXOS, A FRENCH REAL-WORLD DATA ANALYSIS AND THE LARGEST REAL-WORLD DATA ANALYSIS ON ORAL ANTICOAGULANT EFFECTIVENESS AND SAFETY IN EUROPE AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
Eliquis® (apixaban) was associated with a lower rate of major bleeding, stroke and systemic thromboembolic events compared to a vitamin K antagonist. Results show Eliquis was associated with a lower rate of major bleeding and comparable rates of stroke and systemic thromboembolic events versus dabig...
Saved in:
| Main Author: | article Editorial |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2019-12-01
|
| Series: | Евразийский Кардиологический Журнал |
| Online Access: | https://www.heartj.asia/jour/article/view/353 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The optimal timing for initiating oral anticoagulant in ischemic stroke combined with non-valvular atrial fibrillation patients: A real-world big data analysis
by: Wenxuan Lv, et al.
Published: (2025-07-01) -
Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data
by: A. I. Listratov, et al.
Published: (2024-10-01) -
Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
by: Craig I. Coleman, et al.
Published: (2019-01-01) -
NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING
by: Zh. D. Kobalava, et al.
Published: (2018-05-01) -
Anticoagulation in Atrial Fibrillation With Valvular Heart Disease
by: Ana Catarina Fonseca, et al.
Published: (2025-02-01)